Profile picture

Doctor Roela Sadushi-Kolici

Medical University of Vienna, Vienna (Austria)
Follow
Logo ESC

Contributor content

Lowering of mean pulmonary arterial pressure is a prognostic marker in pulmonary hypertension patients treated with subcutaneous treprostinil
Presentation
Lowering of mean pulmonary arterial pressure is a prognostic marker in pulmonary hypertension patients treated with subcutaneous treprostinil
Read more
Subcutaneous treprostinil for the treatment of non-operable chronic thromboembolic pulmonary hypertension: a randomized, controlled trial (CTREPH)
Presentation
Subcutaneous treprostinil for the treatment of non-operable chronic thromboembolic pulmonary hypertension: a randomized, controlled trial (CTREPH)
Read more

ESC 365 is supported by

novartis Explore sponsored resources